Obaid S. Shaikh, MD, FRCP
Director, Transplantation Medicine
VA Pittsburgh Healthcare System
Pittsburgh, PA
Â
Professor of Medicine, School of Medicine
University of Pittsburgh
Pittsburgh, PA
Dr. Shaikh is a graduate of Dow Medical College in Karachi, Pakistan. He completed internships in medicine and surgery at Civil Hospital in Karachi, Pakistan. He completed his residency in gastroenterology at Whiston Hospital Prescot, UK, and in medicine at Goodhope Hospital in Sutton Coldfield, UK. He completed fellowships in hepatology at the University of Southern California in Los Angeles, Calif., and in transplantation medicine at the University of Pittsburgh in Pittsburgh. He is a member of the Association of Physicians of Pakistani-Descent in North America, Dow Graduates Association of North America and American Association for the Study of Liver Diseases.
He is a fellow of the Royal College of Physicians, London, UK, and a diplomate of gastroenterology at the American Board of Internal Medicine.
Dr. Shaikh established the Center for Liver Diseases at the University of Pittsburgh Medical Center and during his tenure at the National Institutes of Health (NIH) in Bethesda, Dr. Shaikh conducted seminal studies on hepatitis C that are among the most cited in literature. His paper on hepatitis delta was one of the earliest that helped define delta genotypes. His clinical trial of pentoxyfylline led to rapid adoption of the drug as standard therapy for acute alcoholic hepatitis.
Dr. Shaikh was a founding member of the Acute Liver Failure Study Group (ALFSG) which has produced a number of important publications and is internationally recognized for advancing the understanding of this life-threatening condition.
His current research focus is hepatic steatosis, advanced chronic liver disease and hepatocellular carcinoma.